{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T22:35:32Z","timestamp":1780439732503,"version":"3.54.1"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T00:00:00Z","timestamp":1778457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T00:00:00Z","timestamp":1778457600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol. Res. Pract."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The greatest impact on the burden of CNS infections resulted from preventive measures, mainly vaccination programs, that have decreased the incidence of many CNS infections significantly. Here, we highlight the main cornerstones of vaccination programs on bacterial and viral CNS infections and point at future chances of upcoming vaccines.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main body<\/jats:title>\n                    <jats:p>Vaccination programs have significantly decreased the number of cases due to Haemophilus influenzae type B and Neisseria meningitidis. For pneumococcal meningitis, new vaccines that prevent neuroinvasive serotypes have the potential to decrease numbers in the future. Whereas a vaccine is available for tick-borne encephalitis, prevention of neuroborreliosis is limited to contact precautions. However, vaccination rates against tick-borne encephalitis remain too low in many countries. Another neurotropic virus that can be prevented effectively by vaccination is varicella zoster virus (VZV). Interestingly, vaccination against VZV also seems to reduce the risk of dementia as recently shown. While vaccination is important in general, patients with immunosuppression benefit most from vaccinations. Finally, recent measles outbreaks impressively underline the efficacy of vaccination programs and demonstrate what can happens if vaccination rates decrease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Vaccination programs have shown to be effective in reducing the burden of CNS infections. As vaccination rates are generally still too low and as new vaccines are coming up, it is obvious that the potential of vaccines to prevent CNS infections is not maxed out yet.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s42466-026-00489-1","type":"journal-article","created":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T15:27:11Z","timestamp":1778513231000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Prevention of neuroinfectious-diseases: high impact of vaccination programs \u2013 but the potential is not maxed out yet"],"prefix":"10.1186","volume":"8","author":[{"given":"Matthias","family":"Klein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximilian","family":"Sch\u00f6ls","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayrettin","family":"Tumani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uta","family":"Meyding-Lamade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Decker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Maschke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,11]]},"reference":[{"issue":"1","key":"489_CR1","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s42466-023-00264-6","volume":"5","author":"M Klein","year":"2023","unstructured":"Klein, M., Abdel-Hadi, C., B\u00fchler, R., Grabein, B., Linn, J., Nau, R., Salzberger, B., Schl\u00fcter, D., Schwager, K., Tumani, H., Weber, J., & Pfister, H. W. (2023). German guidelines on community-acquired acute bacterial meningitis in adults. Neurol Res Pract, 5(1), 44. https:\/\/doi.org\/10.1186\/s42466-023-00264-6","journal-title":"Neurol Res Pract"},{"issue":"1","key":"489_CR2","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s42466-025-00398-9","volume":"7","author":"J Tebben","year":"2025","unstructured":"Tebben, J., Wiebalck, B., & Schmidt, H. (2025). Observational quality control study: insourcing multi-PCR-impact on the use of anti-infectives for patients with pleocytosis. Neurol Res Pract, 7(1), 42. https:\/\/doi.org\/10.1186\/s42466-025-00398-9","journal-title":"Neurol Res Pract"},{"issue":"4","key":"489_CR3","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/S1474-4422(24)00038-3","volume":"23","author":"GBDNSD Collaborators","year":"2024","unstructured":"Collaborators, G. B. D. N. S. D. (2024). Global, regional, and national burden of disorders affecting the nervous system, 1990\u20132021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet Neurology, 23(4), 344\u2013381. https:\/\/doi.org\/10.1016\/S1474-4422(24)00038-3","journal-title":"Lancet Neurology"},{"issue":"5","key":"489_CR4","doi-asserted-by":"publisher","first-page":"e1099","DOI":"10.1093\/cid\/ciaa1774","volume":"73","author":"DLH Koelman","year":"2021","unstructured":"Koelman, D. L. H., van Kassel, M. N., Bijlsma, M. W., Brouwer, M. C., van de Beek, D., & van der Ende, A. (2021). Changing Epidemiology of Bacterial Meningitis Since Introduction of Conjugate Vaccines: 3 Decades of National Meningitis Surveillance in The Netherlands. Clinical Infectious Diseases, 73(5), e1099\u2013e1107. https:\/\/doi.org\/10.1093\/cid\/ciaa1774","journal-title":"Clinical Infectious Diseases"},{"issue":"8","key":"489_CR5","doi-asserted-by":"publisher","first-page":"e2424802","DOI":"10.1001\/jamanetworkopen.2024.24802","volume":"7","author":"CN van Ettekoven","year":"2024","unstructured":"van Ettekoven, C. N., Liechti, F. D., Brouwer, M. C., Bijlsma, M. W., & van de Beek, D. (2024). Global Case Fatality of Bacterial Meningitis During an 80-Year Period: A Systematic Review and Meta-Analysis. JAMA Network Open, 7(8), e2424802. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.24802","journal-title":"JAMA Network Open"},{"key":"489_CR6","doi-asserted-by":"publisher","first-page":"e57","DOI":"10.1017\/s0950268823000328","volume":"151","author":"C Pardo de Santayana","year":"2023","unstructured":"Pardo de Santayana, C., Tin TinHtar, M., Findlow, J., & Balmer, P. (2023). Epidemiology of invasive meningococcal disease worldwide from 2010\u20132019: a literature review. Epidemiology and Infection, 151, e57. https:\/\/doi.org\/10.1017\/s0950268823000328","journal-title":"Epidemiology and Infection"},{"key":"489_CR7","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.Es.2025.30.31.2500509","author":"H Campbell","year":"2025","unstructured":"Campbell, H., Lucidarme, J., Clark, S. A., Heymer, E. J., Ribeiro, S., Bai, X., Ahmad, S., Ramsay, M. E., Borrow, R., & Ladhani, S. N. (2025). Increase in serogroup W invasive meningococcal disease in England associated with pilgrimage to Saudi Arabia, January 2024 to June 2025. Eurosurveillance Weekly. https:\/\/doi.org\/10.2807\/1560-7917.Es.2025.30.31.2500509","journal-title":"Eurosurveillance Weekly"},{"issue":"1","key":"489_CR8","doi-asserted-by":"publisher","first-page":"7706","DOI":"10.1038\/s41467-023-43528-0","volume":"14","author":"L Zhong","year":"2023","unstructured":"Zhong, L., Zhang, M., Sun, L., Yang, Y., Wang, B., Yang, H., Shen, Q., Xia, Y., Cui, J., Hang, H., Ren, Y., Pang, B., Deng, X., Zhan, Y., Li, H., & Zhou, Z. (2023). Distributed genotyping and clustering of Neisseria strains reveal continual emergence of epidemic meningococcus over a century. Nature Communications, 14(1), 7706. https:\/\/doi.org\/10.1038\/s41467-023-43528-0","journal-title":"Nature Communications"},{"key":"489_CR9","unstructured":"RKI. (2022). Epidemiologisches Bulletin, 1."},{"key":"489_CR10","unstructured":"RKI. (2025). Epidemiologisches Bulletin, 1."},{"issue":"7","key":"489_CR11","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1007\/s40121-025-01166-7","volume":"14","author":"J Presa","year":"2025","unstructured":"Presa, J., Carrico, R., Fergie, J. E., Hanenberg, S., Marshall, G. S., Rivard, K., Shaw, J., Zimet, G. D., Peyrani, P., & Cane, A. (2025). Preventing Meningococcal Disease in US Adolescents and Young Adults Through Vaccination. Infectious Disease and Therapy, 14(7), 1381\u20131403. https:\/\/doi.org\/10.1007\/s40121-025-01166-7","journal-title":"Infectious Disease and Therapy"},{"key":"489_CR12","doi-asserted-by":"publisher","first-page":"101120","DOI":"10.1016\/j.lana.2025.101120","volume":"47","author":"N Prasad","year":"2025","unstructured":"Prasad, N., Kobayashi, M., Collins, J. P., Rubis, A. B., Derado, G., Delahoy, M. J., Payne, D. C., McGee, L., Chochua, S., Marjuki, H., McNamara, L. A., Fox, L. M., Reingold, A., Barnes, M., Petit, S., Farley, M. M., Harrison, L. H., Lynfield, R., Houston, J., \u2026 Arvay, M. (2025). The epidemiology of bacterial meningitis in the United States during 2008\u20132023: an analysis of active, laboratory, population-based, multistate surveillance data. Lancet Reg Health Am, 47, 101120. https:\/\/doi.org\/10.1016\/j.lana.2025.101120","journal-title":"Lancet Reg Health Am"},{"issue":"21","key":"489_CR13","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.1056\/NEJMoa1005384","volume":"364","author":"MC Thigpen","year":"2011","unstructured":"Thigpen, M. C., Whitney, C. G., Messonnier, N. E., Zell, E. R., Lynfield, R., Hadler, J. L., Harrison, L. H., Farley, M. M., Reingold, A., Bennett, N. M., Craig, A. S., Schaffner, W., Thomas, A., Lewis, M. M., Scallan, E., & Schuchat, A. (2011). Bacterial meningitis in the United States, 1998\u20132007. New England Journal of Medicine, 364(21), 2016\u20132025. https:\/\/doi.org\/10.1056\/NEJMoa1005384","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"489_CR14","doi-asserted-by":"publisher","first-page":"106426","DOI":"10.1016\/j.jinf.2025.106426","volume":"90","author":"Y Yang","year":"2025","unstructured":"Yang, Y., Knoll, M. D., Herbert, C., Bennett, J. C., Feikin, D. R., Garcia Quesada, M., Hetrich, M. K., Zeger, S. L., Kagucia, E. W., Xiao, M., Cohen, A. L., van der Linden, M., du Plessis, M., Yildirim, I., Winje, B. A., Varon, E., Valenzuela, M. T., Valentiner-Branth, P., Steens, A., \u2026 Team, P. (2025). Global impact of 10- and 13-valent pneumococcal conjugate vaccines on pneumococcal meningitis in all ages: The PSERENADE project. Journal of Infection, 90(3), 106426. https:\/\/doi.org\/10.1016\/j.jinf.2025.106426","journal-title":"Journal of Infection"},{"key":"489_CR15","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-022-11034-w","author":"S V\u00f6lk","year":"2022","unstructured":"V\u00f6lk, S., Pfirrmann, M., Koedel, U., Pfister, H. W., Lang, T., Scheibe, F., Salih, F., Herzig-Nichtweiss, J., Zimmermann, J., Alonso, A., Wittstock, M., Totzeck, A., Schramm, P., Schirotzek, I., Onur, O. A., Pelz, J. O., Ottomeyer, C., Luger, S., Barlinn, K., \u2026 Klein, M. (2022). Decline in the number of patients with meningitis in German hospitals during the COVID-19 pandemic. Journal of Neurology. https:\/\/doi.org\/10.1007\/s00415-022-11034-w","journal-title":"Journal of Neurology"},{"issue":"4","key":"489_CR16","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1002\/ohn.1115","volume":"172","author":"J Hayden","year":"2025","unstructured":"Hayden, J., Youner, E. R., Rosen, R., Cleveland, C. N., Warren, D. A., Mowry, S., Otteson, T. D., & Semaan, M. (2025). Assessing the Impact of Vaccination Status on Meningitis Risk Post Cochlear Implantation. Otolaryngology - Head and Neck Surgery, 172(4), 1374\u20131378. https:\/\/doi.org\/10.1002\/ohn.1115","journal-title":"Otolaryngology - Head and Neck Surgery"},{"key":"489_CR17","doi-asserted-by":"publisher","first-page":"110953","DOI":"10.1016\/j.ijfoodmicro.2024.110953","volume":"427","author":"L Mughini-Gras","year":"2025","unstructured":"Mughini-Gras, L., Paganini, J. A., Guo, R., Coipan, C. E., Friesema, I. H. M., van Hoek, A., van den Beld, M., Kuiling, S., Bergval, I., Wullings, B., van der Voort, M., Franz, E., & Dallman, T. J. (2025). Source attribution of Listeria monocytogenes in the Netherlands. International Journal of Food Microbiology, 427, 110953. https:\/\/doi.org\/10.1016\/j.ijfoodmicro.2024.110953","journal-title":"International Journal of Food Microbiology"},{"issue":"5","key":"489_CR18","doi-asserted-by":"publisher","first-page":"e70003","DOI":"10.1002\/mbo3.70003","volume":"13","author":"K Lambrechts","year":"2024","unstructured":"Lambrechts, K., & Rip, D. (2024). Listeria monocytogenes in the seafood industry: Exploring contamination sources, outbreaks, antibiotic susceptibility and genetic diversity. Microbiologyopen, 13(5), e70003. https:\/\/doi.org\/10.1002\/mbo3.70003","journal-title":"Microbiologyopen"},{"issue":"3","key":"489_CR19","doi-asserted-by":"publisher","first-page":"e0352022","DOI":"10.1128\/spectrum.03520-22","volume":"11","author":"S Halbedel","year":"2023","unstructured":"Halbedel, S., Sperle, I., Lachmann, R., Kleta, S., Fischer, M. A., Wamp, S., Holzer, A., L\u00fcth, S., Murr, L., Freitag, C., Espenhain, L., Stephan, R., Pietzka, A., Schj\u00f8rring, S., Bloemberg, G., Wenning, M., Al Dahouk, S., Wilking, H., & Flieger, A. (2023). Large Multicountry Outbreak of Invasive Listeriosis by a Listeria monocytogenes ST394 Clone Linked to Smoked Rainbow Trout, 2020 to 2021. Microbiol Spectr, 11(3), e0352022. https:\/\/doi.org\/10.1128\/spectrum.03520-22","journal-title":"Microbiol Spectr"},{"key":"489_CR20","doi-asserted-by":"publisher","DOI":"10.57187\/s.3745","author":"C Speich","year":"2024","unstructured":"Speich, C., Stephan, R., Dhima, N., Hollenstein, F., Horlbog, J., Delvento, G., Altpeter, E., Zuske, M., Raess, M., & Greter, H. (2024). Rapid detection of the source of a Listeria monocytogenes outbreak in Switzerland through routine interviewing of patients and whole-genome sequencing. Swiss Medical Weekly. https:\/\/doi.org\/10.57187\/s.3745","journal-title":"Swiss Medical Weekly"},{"issue":"21","key":"489_CR21","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1001\/jama.2022.20521","volume":"328","author":"R Hasbun","year":"2022","unstructured":"Hasbun, R. (2022). Progress and Challenges in Bacterial Meningitis: A Review. JAMA, 328(21), 2147\u20132154. https:\/\/doi.org\/10.1001\/jama.2022.20521","journal-title":"JAMA"},{"issue":"12","key":"489_CR22","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1093\/cid\/ciy838","volume":"68","author":"SL Hillier","year":"2019","unstructured":"Hillier, S. L., Ferrieri, P., Edwards, M. S., Ewell, M., Ferris, D., Fine, P., Carey, V., Meyn, L., Hoagland, D., Kasper, D. L., Paoletti, L. C., Hill, H., & Baker, C. J. (2019). A Phase 2, Randomized, Control Trial of Group B Streptococcus (GBS) Type III Capsular Polysaccharide-tetanus Toxoid (GBS III-TT) Vaccine to Prevent Vaginal Colonization With GBS III. Clinical Infectious Diseases, 68(12), 2079\u20132086. https:\/\/doi.org\/10.1093\/cid\/ciy838","journal-title":"Clinical Infectious Diseases"},{"issue":"9627","key":"489_CR23","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1016\/s0140-6736(08)60800-4","volume":"371","author":"L Lindquist","year":"2008","unstructured":"Lindquist, L., & Vapalahti, O. (2008). Tick-borne encephalitis. Lancet, 371(9627), 1861\u20131871. https:\/\/doi.org\/10.1016\/s0140-6736(08)60800-4","journal-title":"Lancet"},{"issue":"6","key":"489_CR24","doi-asserted-by":"publisher","first-page":"102407","DOI":"10.1016\/j.ttbdis.2024.102407","volume":"15","author":"K Halsby","year":"2024","unstructured":"Halsby, K., Gildea, L., Madhava, H., Angulo, F. J., Pilz, A., Erber, W., Moisi, J., Schley, K., Colosia, A., & Sellner, J. (2024). Clinical manifestations and outcomes of Tick-borne encephalitis: A systematic literature review. Ticks Tick Borne Dis, 15(6), 102407. https:\/\/doi.org\/10.1016\/j.ttbdis.2024.102407","journal-title":"Ticks Tick Borne Dis"},{"key":"489_CR25","unstructured":"RKI. (2024). Epidemiologisches Bulletin, 1."},{"issue":"5","key":"489_CR26","doi-asserted-by":"publisher","first-page":"101972","DOI":"10.1016\/j.ttbdis.2022.101972","volume":"13","author":"VA Jenkins","year":"2022","unstructured":"Jenkins, V. A., Silbernagl, G., Baer, L. R., & Hoet, B. (2022). The epidemiology of infectious diseases in Europe in 2020 versus 2017\u20132019 and the rise of tick-borne encephalitis (1995\u20132020). Ticks Tick Borne Dis, 13(5), 101972. https:\/\/doi.org\/10.1016\/j.ttbdis.2022.101972","journal-title":"Ticks Tick Borne Dis"},{"key":"489_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms10071283","author":"M Kunze","year":"2022","unstructured":"Kunze, M., Banovi\u0107, P., Bogovi\u010d, P., Briciu, V., \u010civljak, R., Dobler, G., Hristea, A., Kerlik, J., Kuivanen, S., Kyn\u010dl, J., Lebech, A. M., Lindquist, L., Paradowska-Stankiewicz, I., Rogli\u0107, S., Sm\u00ed\u0161kov\u00e1, D., Strle, F., Vapalahti, O., Vranje\u0161, N., Vynograd, N., \u2026 Erber, W. (2022). Recommendations to Improve Tick-Borne Encephalitis Surveillance and Vaccine Uptake in Europe. Microorganisms. https:\/\/doi.org\/10.3390\/microorganisms10071283","journal-title":"Microorganisms"},{"key":"489_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms10112125","author":"D Lang","year":"2022","unstructured":"Lang, D., Chitimia-Dobler, L., Bestehorn-Willmann, M., Lindau, A., Drehmann, M., Stroppel, G., Hengge, H., Mackenstedt, U., Kaier, K., Dobler, G., & Borde, J. (2022). The Emergence and Dynamics of Tick-Borne Encephalitis Virus in a New Endemic Region in Southern Germany. Microorganisms. https:\/\/doi.org\/10.3390\/microorganisms10112125","journal-title":"Microorganisms"},{"issue":"1","key":"489_CR29","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s10096-022-04509-1","volume":"42","author":"M Waldeck","year":"2023","unstructured":"Waldeck, M., Winqvist, N., Henriksson, G., Dyrdak, R., Settergren, B., & Lindgren, P. E. (2023). Surveillance of tick-borne encephalitis in emerging risk areas in southern Sweden: a retrospective case finding study. European Journal of Clinical Microbiology and Infectious Diseases, 42(1), 13\u201322. https:\/\/doi.org\/10.1007\/s10096-022-04509-1","journal-title":"European Journal of Clinical Microbiology and Infectious Diseases"},{"issue":"1","key":"489_CR30","doi-asserted-by":"publisher","first-page":"S50","DOI":"10.1016\/s0264-410x(02)00813-7","volume":"21","author":"C Kunz","year":"2003","unstructured":"Kunz, C. (2003). TBE vaccination and the Austrian experience. Vaccine, 21(1), S50-55. https:\/\/doi.org\/10.1016\/s0264-410x(02)00813-7","journal-title":"Vaccine"},{"key":"489_CR31","doi-asserted-by":"publisher","first-page":"127854","DOI":"10.1016\/j.vaccine.2025.127854","volume":"66","author":"S Raffl","year":"2025","unstructured":"Raffl, S., Springer, D. N., Aberle, S. W., Florian, D. M., Kundi, M., Stiasny, K., & Aberle, J. H. (2025). Tick-borne encephalitis: Burden of disease and impact of vaccination, Austria (2000\u20132024). Vaccine, 66, 127854. https:\/\/doi.org\/10.1016\/j.vaccine.2025.127854","journal-title":"Vaccine"},{"issue":"1","key":"489_CR32","doi-asserted-by":"publisher","first-page":"11706","DOI":"10.1038\/s41598-022-15447-5","volume":"12","author":"TM Nygren","year":"2022","unstructured":"Nygren, T. M., Pilic, A., B\u00f6hmer, M. M., Wagner-Wiening, C., Wichmann, O., Harder, T., & Hellenbrand, W. (2022). Tick-borne encephalitis vaccine effectiveness and barriers to vaccination in Germany. Science and Reports, 12(1), 11706. https:\/\/doi.org\/10.1038\/s41598-022-15447-5","journal-title":"Science and Reports"},{"key":"489_CR33","unstructured":"RKI. (2023). Epidemiologisches Bulletin, 14."},{"key":"489_CR34","doi-asserted-by":"publisher","first-page":"101876","DOI":"10.1016\/j.tmaid.2020.101876","volume":"37","author":"JE Rampa","year":"2020","unstructured":"Rampa, J. E., Askling, H. H., Lang, P., Zens, K. D., G\u00fcltekin, N., Stanga, Z., & Schlagenhauf, P. (2020). Immunogenicity and safety of the tick-borne encephalitis vaccination (2009\u20132019): A systematic review. Travel Medicine and Infectious Disease, 37, 101876. https:\/\/doi.org\/10.1016\/j.tmaid.2020.101876","journal-title":"Travel Medicine and Infectious Disease"},{"issue":"1","key":"489_CR35","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s40794-025-00262-3","volume":"11","author":"AD Singh","year":"2025","unstructured":"Singh, A. D., Oberoi, S., Batish, R., Singh, K., Kaur, M., Sidhu, S. K., Kaur, A., & Singh, P. (2025). One-step ahead: evaluating the efficacy of single-visit rabies pre-exposure prophylaxis against conventional multi-visit protocol: a randomized non-inferiority clinical trial. Trop Dis Travel Med Vaccines, 11(1), 25. https:\/\/doi.org\/10.1186\/s40794-025-00262-3","journal-title":"Trop Dis Travel Med Vaccines"},{"issue":"1","key":"489_CR36","doi-asserted-by":"publisher","first-page":"2437244","DOI":"10.1080\/22221751.2024.2437244","volume":"14","author":"P Singh","year":"2025","unstructured":"Singh, P., Khatib, M. N., Ballal, S., Kaur, M., Nathiya, D., Sharma, S., Prasad, G. V. S., Sinha, A., Gaidhane, A. M., Mohapatra, P., Varma, A., Lakhanpal, S., Shabil, M., Bushi, G., Sah, S., & Abu Serhan, H. (2025). West Nile Virus in a changing climate: epidemiology, pathology, advances in diagnosis and treatment, vaccine designing and control strategies, emerging public health challenges - a comprehensive review. Emerg Microbes Infect, 14(1), 2437244. https:\/\/doi.org\/10.1080\/22221751.2024.2437244","journal-title":"Emerg Microbes Infect"},{"key":"489_CR37","doi-asserted-by":"publisher","DOI":"10.3205\/000279","author":"S Rauer","year":"2020","unstructured":"Rauer, S., Kastenbauer, S., Hofmann, H., Fingerle, V., Huppertz, H. I., Hunfeld, K. P., Krause, A., Ruf, B., & Dersch, R. (2020). Guidelines for diagnosis and treatment in neurology - Lyme neuroborreliosis. German Medical Science. https:\/\/doi.org\/10.3205\/000279","journal-title":"German Medical Science"},{"issue":"1","key":"489_CR38","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/zph.13191","volume":"72","author":"A Davidson","year":"2025","unstructured":"Davidson, A., Kelly, P. H., Davis, J., Major, M., Mo\u00efsi, J. C., & Stark, J. H. (2025). Historical Summary of Tick and Animal Surveillance Studies for Lyme Disease in Canada, 1975\u20132023: A Scoping Review. Zoonoses and Public Health, 72(1), 9\u201322. https:\/\/doi.org\/10.1111\/zph.13191","journal-title":"Zoonoses and Public Health"},{"key":"489_CR39","doi-asserted-by":"publisher","first-page":"105701","DOI":"10.1016\/j.ebiom.2025.105701","volume":"115","author":"ML Batista","year":"2025","unstructured":"Batista, M. L., Carvalho, B., Gibb, R., Solaraju-Murali, B., Flasche, S., Castell, S., Ghozzi, S., & Lowe, R. (2025). Modelling the impact of climate and the environment on the spatiotemporal dynamics of Lyme borreliosis in Germany. eBioMedicine, 115, 105701. https:\/\/doi.org\/10.1016\/j.ebiom.2025.105701","journal-title":"eBioMedicine"},{"issue":"4","key":"489_CR40","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1089\/vbz.2022.0046","volume":"23","author":"J Skufca","year":"2023","unstructured":"Skufca, J., Tran, T. M. P., Brestrich, G., Pilz, A., Vyse, A., Malerczyk, C., Dzingina, M., Begier, E., Blum, M., Riera-Montes, M., Gessner, B. D., & Stark, J. H. (2023). Incidence of Lyme Borreliosis in Germany: Exploring Observed Trends Over Time Using Public Surveillance Data, 2016\u20132020. Vector Borne and Zoonotic Diseases, 23(4), 237\u2013246. https:\/\/doi.org\/10.1089\/vbz.2022.0046","journal-title":"Vector Borne and Zoonotic Diseases"},{"issue":"2","key":"489_CR41","doi-asserted-by":"publisher","first-page":"102514","DOI":"10.1016\/j.omtn.2025.102514","volume":"36","author":"D Tahir","year":"2025","unstructured":"Tahir, D., Geolier, V., Bruant, H., Le Fl\u00e8che-Mat\u00e9os, A., Mallet, A., Varloud, M., Civat, C., Girerd-Chambaz, Y., Montano, S., Pion, C., Ferquel, E., Pavot, V., & Choumet, V. (2025). A Lyme disease mRNA vaccine targeting Borrelia burgdorferi OspA induces strong immune responses and prevents transmission in mice. Mol Ther Nucleic Acids, 36(2), 102514. https:\/\/doi.org\/10.1016\/j.omtn.2025.102514","journal-title":"Mol Ther Nucleic Acids"},{"issue":"9","key":"489_CR42","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/s1473-3099(24)00175-0","volume":"24","author":"N B\u00e9zay","year":"2024","unstructured":"B\u00e9zay, N., Wagner, L., Kadlecek, V., Obersriebnig, M., Wressnigg, N., Hochreiter, R., Schneider, M., Dubischar, K., Derhaschnig, U., Klingler, A., Larcher-Senn, J., Eder-Lingelbach, S., & Bender, W. (2024). Optimisation of dose level and vaccination schedule for the VLA15 Lyme borreliosis vaccine candidate among healthy adults: two randomised, observer-blind, placebo-controlled, multicentre, phase 2 studies. The Lancet Infectious Diseases, 24(9), 1045\u20131058. https:\/\/doi.org\/10.1016\/s1473-3099(24)00175-0","journal-title":"The Lancet Infectious Diseases"},{"key":"489_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/s1473-3099(25)00541-9","author":"L Wagner","year":"2025","unstructured":"Wagner, L., Obersriebnig, M., Hochreiter, R., Kadlecek, V., Larcher-Senn, J., Hegele, L., Maguire, J. D., Murphy, T., Derhaschnig, U., B\u00e9zay, N., Jaramillo, J. C., Eder-Lingelbach, S., & Messier, M. (2025). Immunogenicity and safety of an 18-month booster dose of the VLA15 Lyme borreliosis vaccine candidate after primary immunisation in children, adolescents, and adults in the USA: a randomised, observer-blind, placebo-controlled, phase 2 trial. The Lancet Infectious Diseases. https:\/\/doi.org\/10.1016\/s1473-3099(25)00541-9","journal-title":"The Lancet Infectious Diseases"},{"issue":"9","key":"489_CR44","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1016\/s1473-3099(25)00092-1","volume":"25","author":"L Wagner","year":"2025","unstructured":"Wagner, L., Obersriebnig, M., Kadlecek, V., Hochreiter, R., Ghadge, S. K., Larcher-Senn, J., Hegele, L., Maguire, J. D., Derhaschnig, U., Jaramillo, J. C., Eder-Lingelbach, S., & B\u00e9zay, N. (2025). Immunogenicity and safety of different immunisation schedules of the VLA15 Lyme borreliosis vaccine candidate in adults, adolescents, and children: a randomised, observer-blind, placebo-controlled, phase 2 trial. The Lancet Infectious Diseases, 25(9), 986\u2013999. https:\/\/doi.org\/10.1016\/s1473-3099(25)00092-1","journal-title":"The Lancet Infectious Diseases"},{"issue":"1","key":"489_CR45","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1186\/s12879-025-11183-z","volume":"25","author":"K Ost","year":"2025","unstructured":"Ost, K., Norman, M., Dumas, A., Corrin, T., Waddell, L., Schryer, R., Duguay, C., Facchin, O., Zinszer, K., Rocheleau, J. P., Bouchard, C., Aenishaenslin, C., Krentel, A., Feng, C., & Kulkarni, M. A. (2025). A systematic review of the effectiveness and utility of Lyme disease prevention measures in Canada, the United States, and Europe. BMC Infectious Diseases, 25(1), 889. https:\/\/doi.org\/10.1186\/s12879-025-11183-z","journal-title":"BMC Infectious Diseases"},{"issue":"1","key":"489_CR46","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.jinf.2020.06.032","volume":"82","author":"MG Harms","year":"2021","unstructured":"Harms, M. G., Hofhuis, A., Sprong, H., Bennema, S. C., Ferreira, J. A., Fonville, M., Docters van Leeuwen, A., Assendelft, W. J. J., Van Weert, H., Van Pelt, W., & Van den Wijngaard, C. C. (2021). A single dose of doxycycline after an ixodes ricinus tick bite to prevent Lyme borreliosis: An open-label randomized controlled trial. Journal of Infection, 82(1), 98\u2013104. https:\/\/doi.org\/10.1016\/j.jinf.2020.06.032","journal-title":"Journal of Infection"},{"issue":"2","key":"489_CR47","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1056\/nejm200107123450201","volume":"345","author":"RB Nadelman","year":"2001","unstructured":"Nadelman, R. B., Nowakowski, J., Fish, D., Falco, R. C., Freeman, K., McKenna, D., Welch, P., Marcus, R., Ag\u00fcero-Rosenfeld, M. E., Dennis, D. T., & Wormser, G. P. (2001). Prophylaxis with single-dose doxycycline for the prevention of Lyme disease after an Ixodes scapularis tick bite. New England Journal of Medicine, 345(2), 79\u201384. https:\/\/doi.org\/10.1056\/nejm200107123450201","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"489_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/cid\/ciab049","volume":"72","author":"PM Lantos","year":"2021","unstructured":"Lantos, P. M., Rumbaugh, J., Bockenstedt, L. K., Falck-Ytter, Y. T., Aguero-Rosenfeld, M. E., Auwaerter, P. G., Baldwin, K., Bannuru, R. R., Belani, K. K., Bowie, W. R., Branda, J. A., Clifford, D. B., DiMario, F. J., Halperin, J. J., Krause, P. J., Lavergne, V., Liang, M. H., Meissner, H. C., Nigrovic, L. E., \u2026 Zemel, L. S. (2021). Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR): 2020 Guidelines for the Prevention, Diagnosis and Treatment of Lyme Disease. Clinical Infectious Diseases, 72(1), 1\u20138. https:\/\/doi.org\/10.1093\/cid\/ciab049","journal-title":"Clinical Infectious Diseases"},{"key":"489_CR49","first-page":"Doc12","volume":"23","author":"S Rauer","year":"2024","unstructured":"Rauer, S., & S, K. (2024). S3-Leitlinie Neuroborreliose. Deutsche Gesellschaft f\u00fcr Neurologie, Leitlinien f\u00fcr Diagnostik und Thearpie in der Neurologie, 23, Doc12.","journal-title":"Deutsche Gesellschaft f\u00fcr Neurologie, Leitlinien f\u00fcr Diagnostik und Thearpie in der Neurologie"},{"key":"489_CR50","doi-asserted-by":"publisher","first-page":"15016","DOI":"10.1038\/nrdp.2015.16","volume":"1","author":"AA Gershon","year":"2015","unstructured":"Gershon, A. A., Breuer, J., Cohen, J. I., Cohrs, R. J., Gershon, M. D., Gilden, D., Grose, C., Hambleton, S., Kennedy, P. G., Oxman, M. N., Seward, J. F., & Yamanishi, K. (2015). Varicella zoster virus infection. Nature Reviews. Disease Primers, 1, 15016. https:\/\/doi.org\/10.1038\/nrdp.2015.16","journal-title":"Nature Reviews. Disease Primers"},{"issue":"6","key":"489_CR51","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1080\/21645515.2020.1847582","volume":"17","author":"D van Oorschot","year":"2021","unstructured":"van Oorschot, D., Vroling, H., Bunge, E., Diaz-Decaro, J., Curran, D., & Yawn, B. (2021). A systematic literature review of herpes zoster incidence worldwide. Human Vaccines & Immunotherapeutics, 17(6), 1714\u20131732. https:\/\/doi.org\/10.1080\/21645515.2020.1847582","journal-title":"Human Vaccines & Immunotherapeutics"},{"issue":"16","key":"489_CR52","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1056\/NEJMcp1403062","volume":"371","author":"RW Johnson","year":"2014","unstructured":"Johnson, R. W., & Rice, A. S. (2014). Clinical practice. Postherpetic neuralgia. N Engl J Med, 371(16), 1526\u20131533. https:\/\/doi.org\/10.1056\/NEJMcp1403062","journal-title":"Postherpetic neuralgia. N Engl J Med"},{"key":"489_CR53","doi-asserted-by":"publisher","DOI":"10.3390\/v15081663","author":"PGE Kennedy","year":"2023","unstructured":"Kennedy, P. G. E. (2023). The Spectrum of Neurological Manifestations of Varicella-Zoster Virus Reactivation. Viruses. https:\/\/doi.org\/10.3390\/v15081663","journal-title":"Viruses"},{"issue":"5","key":"489_CR54","doi-asserted-by":"publisher","first-page":"e1134","DOI":"10.1542\/peds.2013-0863","volume":"132","author":"SR Bialek","year":"2013","unstructured":"Bialek, S. R., Perella, D., Zhang, J., Mascola, L., Viner, K., Jackson, C., Lopez, A. S., Watson, B., & Civen, R. (2013). Impact of a routine two-dose varicella vaccination program on varicella epidemiology. Pediatrics, 132(5), e1134-1140. https:\/\/doi.org\/10.1542\/peds.2013-0863","journal-title":"Pediatrics"},{"issue":"2","key":"489_CR55","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1542\/peds.2010-3385","volume":"128","author":"M Marin","year":"2011","unstructured":"Marin, M., Zhang, J. X., & Seward, J. F. (2011). Near elimination of varicella deaths in the US after implementation of the vaccination program. Pediatrics, 128(2), 214\u2013220. https:\/\/doi.org\/10.1542\/peds.2010-3385","journal-title":"Pediatrics"},{"key":"489_CR56","doi-asserted-by":"crossref","unstructured":"Siedler, A., & Arndt, U. (2010). Impact of the routine varicella vaccination programme on varicella epidemiology in Germany. Euro Surveill, 15(13).","DOI":"10.2807\/ese.15.13.19530-en"},{"issue":"9","key":"489_CR57","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1097\/INF.0b013e3181e2817f","volume":"29","author":"M Spackova","year":"2010","unstructured":"Spackova, M., Muehlen, M., & Siedler, A. (2010). Complications of varicella after implementation of routine childhood varicella vaccination in Germany. The Pediatric Infectious Disease Journal, 29(9), 884\u2013886. https:\/\/doi.org\/10.1097\/INF.0b013e3181e2817f","journal-title":"The Pediatric Infectious Disease Journal"},{"issue":"11","key":"489_CR58","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1093\/infdis\/jit405","volume":"208","author":"S Weinmann","year":"2013","unstructured":"Weinmann, S., Chun, C., Schmid, D. S., Roberts, M., Vandermeer, M., Riedlinger, K., Bialek, S. R., & Marin, M. (2013). Incidence and clinical characteristics of herpes zoster among children in the varicella vaccine era, 2005\u20132009. Journal of Infectious Diseases, 208(11), 1859\u20131868. https:\/\/doi.org\/10.1093\/infdis\/jit405","journal-title":"Journal of Infectious Diseases"},{"issue":"22","key":"489_CR59","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1056\/NEJMoa051016","volume":"352","author":"MN Oxman","year":"2005","unstructured":"Oxman, M. N., Levin, M. J., Johnson, G. R., Schmader, K. E., Straus, S. E., Gelb, L. D., Arbeit, R. D., Simberkoff, M. S., Gershon, A. A., Davis, L. E., Weinberg, A., Boardman, K. D., Williams, H. M., Zhang, J. H., Peduzzi, P. N., Beisel, C. E., Morrison, V. A., Guatelli, J. C., Brooks, P. A., \u2026 Silber, J. L. (2005). A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. New England Journal of Medicine, 352(22), 2271\u20132284. https:\/\/doi.org\/10.1056\/NEJMoa051016","journal-title":"New England Journal of Medicine"},{"issue":"11","key":"489_CR60","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1056\/NEJMoa1603800","volume":"375","author":"AL Cunningham","year":"2016","unstructured":"Cunningham, A. L., Lal, H., Kovac, M., Chlibek, R., Hwang, S. J., D\u00edez-Domingo, J., Godeaux, O., Levin, M. J., McElhaney, J. E., Puig-Barber\u00e0, J., Vanden Abeele, C., Vesikari, T., Watanabe, D., Zahaf, T., Ahonen, A., Athan, E., Barba-Gomez, J. F., Campora, L., de Looze, F., \u2026 Heineman, T. C. (2016). Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older. New England Journal of Medicine, 375(11), 1019\u20131032. https:\/\/doi.org\/10.1056\/NEJMoa1603800","journal-title":"New England Journal of Medicine"},{"key":"489_CR61","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.Es.2025.30.35.2500077","author":"A Juutinen","year":"2025","unstructured":"Juutinen, A., Salo, H., Lehtonen, T., & Leino, T. (2025). Herpes zoster incidence in adults aged \u2265 20 years in Finland, 2015 to 2023: a population-based register study. Eurosurveillance Weekly. https:\/\/doi.org\/10.2807\/1560-7917.Es.2025.30.35.2500077","journal-title":"Eurosurveillance Weekly"},{"issue":"46","key":"489_CR62","doi-asserted-by":"publisher","first-page":"7072","DOI":"10.1016\/j.vaccine.2018.09.013","volume":"36","author":"P Wutzler","year":"2018","unstructured":"Wutzler, P., Casabona, G., Cnops, J., Akpo, E. I. H., & Safadi, M. A. P. (2018). Herpes zoster in the context of varicella vaccination - An equation with several variables. Vaccine, 36(46), 7072\u20137082.","journal-title":"Vaccine"},{"issue":"8062","key":"489_CR63","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1038\/s41586-025-08800-x","volume":"641","author":"M Eyting","year":"2025","unstructured":"Eyting, M., Xie, M., Michalik, F., He\u00df, S., Chung, S., & Geldsetzer, P. (2025). A natural experiment on the effect of herpes zoster vaccination on dementia. Nature, 641(8062), 438\u2013446. https:\/\/doi.org\/10.1038\/s41586-025-08800-x","journal-title":"Nature"},{"key":"489_CR64","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-025-03972-5","author":"V Polisky","year":"2025","unstructured":"Polisky, V., Littmann, M., Triastcyn, A., Horn, M., Georgiou, A., Widenmaier, R., Anspach, B., Tahrat, H., Kumar, S., Buser-Doepner, C., Geldsetzer, P., Van Duijn, C. M., & Schwab, P. (2025). Varicella-zoster virus reactivation and the risk of dementia. Nature Medicine. https:\/\/doi.org\/10.1038\/s41591-025-03972-5","journal-title":"Nature Medicine"},{"issue":"23","key":"489_CR65","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1001\/jama.2025.5013","volume":"333","author":"M Pomirchy","year":"2025","unstructured":"Pomirchy, M., Bommer, C., Pradella, F., Michalik, F., Peters, R., & Geldsetzer, P. (2025). Herpes Zoster Vaccination and Dementia Occurrence. JAMA, 333(23), 2083\u20132092. https:\/\/doi.org\/10.1001\/jama.2025.5013","journal-title":"JAMA"},{"issue":"10","key":"489_CR66","doi-asserted-by":"publisher","first-page":"2777","DOI":"10.1038\/s41591-024-03201-5","volume":"30","author":"M Taquet","year":"2024","unstructured":"Taquet, M., Dercon, Q., Todd, J. A., & Harrison, P. J. (2024). The recombinant shingles vaccine is associated with lower risk of dementia. Nature Medicine, 30(10), 2777\u20132781. https:\/\/doi.org\/10.1038\/s41591-024-03201-5","journal-title":"Nature Medicine"},{"issue":"7","key":"489_CR67","doi-asserted-by":"publisher","first-page":"e88196","DOI":"10.7759\/cureus.88196","volume":"17","author":"AF Adeoye","year":"2025","unstructured":"Adeoye, A. F., Umoru, D. O., Gomez, O. O., Onifade, I. A., Akangbe, B. O., Elechi, U. S., & Barrah, V. U. (2025). The 2025 United States Measles Crisis: When Vaccine Hesitancy Meets Reality. Cureus, 17(7), e88196. https:\/\/doi.org\/10.7759\/cureus.88196","journal-title":"Cureus"},{"issue":"1","key":"489_CR68","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s42466-025-00375-2","volume":"7","author":"JL Busch","year":"2025","unstructured":"Busch, J. L., Schikora, J., Wackernagel, L. M., Nawabi, J., Endres, M., & Ruprecht, K. (2025). Chronic Candida albicans meningoencephalitis in a patient with mantle cell lymphoma: a diagnostic challenge. Neurol Res Pract, 7(1), 15. https:\/\/doi.org\/10.1186\/s42466-025-00375-2","journal-title":"Neurol Res Pract"},{"key":"489_CR69","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6627e1","author":"LA McNamara","year":"2017","unstructured":"McNamara, L. A., Topaz, N., Wang, X., Hariri, S., Fox, L., & MacNeil, J. R. (2017). High Risk for Invasive Meningococcal Disease Among Patients Receiving Eculizumab (Soliris) Despite Receipt of Meningococcal Vaccine. MMWR. Morbidity and Mortality Weekly Report. https:\/\/doi.org\/10.15585\/mmwr.mm6627e1","journal-title":"MMWR. Morbidity and Mortality Weekly Report"},{"issue":"3","key":"489_CR70","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1007\/s13311-016-0453-3","volume":"13","author":"EC Leibovitch","year":"2016","unstructured":"Leibovitch, E. C., & Jacobson, S. (2016). Vaccinations for Neuroinfectious Disease: A Global Health Priority. Neurotherapeutics, 13(3), 562\u2013570. https:\/\/doi.org\/10.1007\/s13311-016-0453-3","journal-title":"Neurotherapeutics"},{"issue":"5","key":"489_CR71","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/s41582-022-00646-5","volume":"18","author":"A Winkelmann","year":"2022","unstructured":"Winkelmann, A., Loebermann, M., Barnett, M., Hartung, H. P., & Zettl, U. K. (2022). Vaccination and immunotherapies in neuroimmunological diseases. Nature Reviews. Neurology, 18(5), 289\u2013306. https:\/\/doi.org\/10.1038\/s41582-022-00646-5","journal-title":"Nature Reviews. Neurology"},{"key":"489_CR72","doi-asserted-by":"publisher","DOI":"10.1016\/s1473-3099(25)00345-7","author":"JA Hill","year":"2025","unstructured":"Hill, J. A., Boonyaratanakornkit, J., Mikulska, M., Teh, B. W., Hahn, W. O., Haidar, G., Liu, C., Kumar, D., Ison, M. G., & Halasa, N. (2025). Innovation in active and passive immunisation of people who are immunocompromised: A call to action. The Lancet Infectious Diseases. https:\/\/doi.org\/10.1016\/s1473-3099(25)00345-7","journal-title":"The Lancet Infectious Diseases"},{"key":"489_CR73","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines10050800","author":"KC See","year":"2022","unstructured":"See, K. C. (2022). Vaccination for the prevention of infection among immunocompromised patients: a concise review of recent systematic reviews. Vaccines (Basel). https:\/\/doi.org\/10.3390\/vaccines10050800","journal-title":"Vaccines (Basel)"},{"issue":"5","key":"489_CR74","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1007\/s42451-025-00774-4","volume":"8","author":"A Berthele","year":"2025","unstructured":"Berthele, A., Aktas, O., Ayzenberg, I., Claus, H., Lam, T. T., L\u00f6scher, W. N., L\u00fcnemann, J. D., Pr\u00f6bstel, A. K., Pr\u00fcss, H., Rademacher, N., Ringelstein, M., Rommer, P. S., Schara-Schmidt, U., Schoser, B., Weber, J. R., Zsch\u00fcntzsch, J., & Meisel, A. (2025). Expertenkonsensus: Meningokokkenprophylaxe in der Therapie neurologischer Erkrankungen mit Komplementinhibitoren. DGNeurologie, 8(5), 398\u2013407.","journal-title":"DGNeurologie"},{"key":"489_CR75","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.ejpn.2021.10.009","volume":"35","author":"T Golli","year":"2021","unstructured":"Golli, T., Kastrin, A., Pokorn, M., & Rener-Primec, Z. (2021). Immunosuppression and immunization: Vaccination in pediatric patients with neuromuscular diseases treated with steroids or immune-modulating drugs. European J Paediatric Neurol, 35, 158\u2013164. https:\/\/doi.org\/10.1016\/j.ejpn.2021.10.009","journal-title":"European J Paediatric Neurol"},{"issue":"2","key":"489_CR76","doi-asserted-by":"publisher","first-page":"e70108","DOI":"10.1002\/rmv.70108","volume":"36","author":"B Aurelio","year":"2026","unstructured":"Aurelio, B., Kaisar, M. M. M., Wijaya, V., Khustiawan, S. O. R., Hengestu, A., & Ali, S. (2026). A Systematic Review and Meta-Analysis of Global DENV, CHIKV, and ZIKV Co-Infection. Reviews in Medical Virology, 36(2), e70108. https:\/\/doi.org\/10.1002\/rmv.70108","journal-title":"Reviews in Medical Virology"},{"issue":"1","key":"489_CR77","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1186\/s12879-025-12475-0","volume":"26","author":"QY Zuo","year":"2025","unstructured":"Zuo, Q. Y., Lv, W. W., Qin, Y., Yang, J., Zhang, Y. F., Yang, G. B., Zheng, C. J., Zhou, M. G., Wang, J. C., & Zhang, S. X. (2025). Global burden and cross-country inequalities in rabies from 1990 to 2021: a systemic analysis of the global burden of disease study 2021. BMC Infectious Diseases, 26(1), 213. https:\/\/doi.org\/10.1186\/s12879-025-12475-0","journal-title":"BMC Infectious Diseases"},{"key":"489_CR78","doi-asserted-by":"publisher","DOI":"10.3238\/arztebl.m2025.0220","author":"F Reinhardt","year":"2026","unstructured":"Reinhardt, F., Wendt, S., Pfeffer, M., Freuling, C., M\u00fcller, T., & L\u00fcbbert, C. (2026). Rabies in Europe: Epidemiology, Clinical Management, and Prevention. Dtsch Arztebl Int (Forthcoming). https:\/\/doi.org\/10.3238\/arztebl.m2025.0220","journal-title":"Dtsch Arztebl Int (Forthcoming)"},{"key":"489_CR79","unstructured":"RKI. (2009). Aktuelle Statistik meldepflichtiger Infektionskrankheiten. Epidemiologisches Bulletin, 20\/2009. (Not in File)."},{"issue":"7\u20138","key":"489_CR80","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s00508-023-02240-1","volume":"136","author":"FX Heinz","year":"2024","unstructured":"Heinz, F. X. (2024). Development of a\u00a0highly purified tick-borne encephalitis vaccine\u202f: A\u00a0personal historical account. Wiener Klinische Wochenschrift, 136(7\u20138), 215\u2013219. https:\/\/doi.org\/10.1007\/s00508-023-02240-1","journal-title":"Wiener Klinische Wochenschrift"}],"container-title":["Neurological Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42466-026-00489-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s42466-026-00489-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42466-026-00489-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T15:27:14Z","timestamp":1778513234000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s42466-026-00489-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,11]]},"references-count":80,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["489"],"URL":"https:\/\/doi.org\/10.1186\/s42466-026-00489-1","relation":{},"ISSN":["2524-3489"],"issn-type":[{"value":"2524-3489","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,11]]},"assertion":[{"value":"7 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors declare that there are no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"37"}}